1. Home
  2. DRS vs RGEN Comparison

DRS vs RGEN Comparison

Compare DRS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRS
  • RGEN
  • Stock Information
  • Founded
  • DRS 1969
  • RGEN 1981
  • Country
  • DRS United States
  • RGEN United States
  • Employees
  • DRS N/A
  • RGEN N/A
  • Industry
  • DRS Military/Government/Technical
  • RGEN Medical/Dental Instruments
  • Sector
  • DRS Industrials
  • RGEN Health Care
  • Exchange
  • DRS Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • DRS 8.3B
  • RGEN 8.0B
  • IPO Year
  • DRS N/A
  • RGEN N/A
  • Fundamental
  • Price
  • DRS $41.67
  • RGEN $126.50
  • Analyst Decision
  • DRS Buy
  • RGEN Buy
  • Analyst Count
  • DRS 6
  • RGEN 12
  • Target Price
  • DRS $38.33
  • RGEN $172.67
  • AVG Volume (30 Days)
  • DRS 1.1M
  • RGEN 815.5K
  • Earning Date
  • DRS 05-01-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • DRS 0.43%
  • RGEN N/A
  • EPS Growth
  • DRS 25.90
  • RGEN N/A
  • EPS
  • DRS 0.88
  • RGEN N/A
  • Revenue
  • DRS $3,345,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • DRS $9.55
  • RGEN $13.93
  • Revenue Next Year
  • DRS $6.15
  • RGEN $14.35
  • P/E Ratio
  • DRS $47.35
  • RGEN N/A
  • Revenue Growth
  • DRS 13.58
  • RGEN 4.88
  • 52 Week Low
  • DRS $21.98
  • RGEN $102.97
  • 52 Week High
  • DRS $42.62
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • DRS 67.49
  • RGEN 44.61
  • Support Level
  • DRS $40.01
  • RGEN $123.10
  • Resistance Level
  • DRS $43.20
  • RGEN $135.47
  • Average True Range (ATR)
  • DRS 1.59
  • RGEN 6.98
  • MACD
  • DRS -0.07
  • RGEN -0.97
  • Stochastic Oscillator
  • DRS 79.35
  • RGEN 25.20

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: